← FDA DRUG APPROVALS

FDA ANDA · ANDA075775

POTASSIUM CHLORIDE

Sponsor: ELAN PHARM

APPLICATION
ANDA075775
TYPE
ANDA
ROUTE
Oral
DOSAGE FORM
Tablet, Extended Release
MARKETING STATUS
None (Tentative Approval)

Products

POTASSIUM CHLORIDENone (Tentative Approval)
POTASSIUM CHLORIDE 10MEQ · Tablet, Extended Release · Oral

Approval history

2001-06-28OriginalTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →